GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » Sale Of Business

Actinogen Medical (Actinogen Medical) Sale Of Business : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Actinogen Medical Sale Of Business?

Actinogen Medical's sale of business for the six months ended in Dec. 2023 was $0.00 Mil. It means Actinogen Medical gained $0.00 Mil from selling business. Actinogen Medical's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2023 ), Actinogen Medical gained the same money from selling business in Dec. 2023 ($0.00 Mil).

Actinogen Medical Sale Of Business Historical Data

The historical data trend for Actinogen Medical's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Sale Of Business Chart

Actinogen Medical Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Actinogen Medical Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Actinogen Medical Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actinogen Medical Sale Of Business Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical (Actinogen Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » Sale Of Business
Comparable Companies
ASX:AGN ASX:OCC ASX:SPL ASX:ADO ASX:BIT ASX:PAR ASX:PAA ASX:PTX ASX:EZZ ASX:CYP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
3AC:Germany ACW:Australia
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Website
https://www.actinogen.com.au
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.